The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Self-citationKeele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationBroad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y. K., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011) · Science · doi:10.1126/science.1207227 · Cited by 1,139
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
Self-citationStructure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
McLellan, J. S., Chen, M., Joyce, M. G., Sastry, M., Stewart-Jones, G. B. E., Yang, Y., Zhang, B., Chen, L., Srivatsan, S., Zheng, A., et al. (2013) · Science · doi:10.1126/science.1243283 · Cited by 1,126
Self-citationEfficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Timing the ancestor of the HIV-1 pandemic strains.
Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B. H., Wolinsky, S., & Bhattacharya, T. (2000) · Science · doi:10.1126/science.288.5472.1789 · Cited by 1,021
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Liao, H.-X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., et al. (2013) · Nature · doi:10.1038/nature12053 · Cited by 988
Self-citationZhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Self-citationSelf-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
McLellan, J. S., Chen, M., Leung, S., Graepel, K. W., Du, X., Yang, Y., Zhou, T., Baxa, U., Yasuda, E., Beaumont, T., et al. (2013) · Science · doi:10.1126/science.1234914 · Cited by 883
Self-citationStructure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J.-P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., et al. (2011) · Nature · doi:10.1038/nature10696 · Cited by 830
Self-citationBroad and potent neutralization of HIV-1 by a gp41-specific human antibody
Huang, J., Ofek, G., Laub, L., Louder, M. K., Doria-Rose, N. A., Longo, N. S., Imamichi, H., Bailer, R. T., Chakrabarti, B., Sharma, S. K., et al. (2012) · Nature · doi:10.1038/nature11544 · Cited by 828
Self-citationA Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 822
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Julien, J.-P., Cupo, A., Sok, D., Stanfield, R. L., Lyumkis, D., Deller, M. C., Klasse, P.-J., Burton, D. R., Sanders, R. W., Moore, J. P., et al. (2013) · Science · doi:10.1126/science.1245625 · Cited by 797
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Wu, X., Zhou, T., Zhu, J., Zhang, B., Georgiev, I., Wang, C., Chen, X., Longo, N. S., Louder, M., McKee, K., et al. (2011) · Science · doi:10.1126/science.1207532 · Cited by 784
Self-citationAntibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770
Self-citationRational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Caskey, M., Klein, F., Lorenzi, J. C. C., Seaman, M. S., West, A. P., Buckley, N., Kremer, G., Nogueira, L., Braunschweig, M., Scheid, J. F., et al. (2015) · Nature · doi:10.1038/nature14411 · Cited by 767
HIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Self-citationProtection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
Seder, R. A., Chang, L.-J., Enama, M. E., Zephir, K. L., Sarwar, U. N., Gordon, I. J., Holman, L. A., James, E. R., Billingsley, P. F., Gunasekera, A., et al. (2013) · Science · doi:10.1126/science.1241800 · Cited by 761
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., et al. (2005) · Science · doi:10.1126/science.1111781 · Cited by 744
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Pancera, M., Zhou, T., Druz, A., Georgiev, I. S., Soto, C., Gorman, J., Huang, J., Acharya, P., Chuang, G.-Y., Ofek, G., et al. (2014) · Nature · doi:10.1038/nature13808 · Cited by 740
Self-citationDevelopmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Doria-Rose, N. A., Schramm, C. A., Gorman, J., Moore, P. L., Bhiman, J. N., DeKosky, B. J., Ernandes, M. J., Georgiev, I. S., Kim, H. J., Pancera, M., et al. (2014) · Nature · doi:10.1038/nature13036 · Cited by 709
Self-citationA Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
Lyumkis, D., Julien, J.-P., de Val, N., Cupo, A., Potter, C. S., Klasse, P.-J., Burton, D. R., Sanders, R. W., Moore, J. P., Carragher, B., et al. (2013) · Science · doi:10.1126/science.1245627 · Cited by 669
Scanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Barouch, D. H., Whitney, J. B., Moldt, B., Klein, F., Oliveira, T. Y., Liu, J., Stephenson, K. E., Chang, H.-W., Shekhar, K., Gupta, S., et al. (2013) · Nature · doi:10.1038/nature12744 · Cited by 644
Antibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637
Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission
Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., et al. (2004) · Science · doi:10.1126/science.1093137 · Cited by 617
Simek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00110-09 · Cited by 594
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Burton, D. R., & Hangartner, L. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055515 · Cited by 583
Proof of principle for epitope-focused vaccine design
Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Self-citationComplex-type N -glycan recognition by potent broadly neutralizing HIV antibodies
Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 550
Evolutionary and immunological implications of contemporary HIV-1 variation
Korber, B., Gaschen, B., Yusim, K., Thakallapally, R., Kesmir, C., & Detours, V. (2001) · British Medical Bulletin · doi:10.1093/bmb/58.1.19 · Cited by 540
Sather, D. N., Armann, J., Ching, L. K., Mavrantoni, A., Sellhorn, G., Caldwell, Z., Yu, X., Wood, B., Self, S., Kalams, S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02036-08 · Cited by 528
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions
Munro, J. B., Gorman, J., Ma, X., Zhou, Z., Arthos, J., Burton, D. R., Koff, W. C., Courter, J. R., Smith, A. B., Kwong, P. D., et al. (2014) · Science · doi:10.1126/science.1254426 · Cited by 492
Self-citationOfek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., & Kwong, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10724-10737.2004 · Cited by 490
Self-citationAntibody 10-1074 suppresses viremia in HIV-1-infected individuals
Caskey, M., Schoofs, T., Gruell, H., Settler, A., Karagounis, T., Kreider, E. F., Murrell, B., Pfeifer, N., Nogueira, L., Oliveira, T. Y., et al. (2017) · Nature Medicine · doi:10.1038/nm.4268 · Cited by 487
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 486
HIV‐1 neutralizing antibodies: understanding nature's pathways
Mascola, J. R., & Haynes, B. F. (2013) · Immunological Reviews · doi:10.1111/imr.12075 · Cited by 475
Self-citationHIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Scheid, J. F., Horwitz, J. A., Bar-On, Y., Kreider, E. F., Lu, C.-L., Lorenzi, J. C. C., Feldmann, A., Braunschweig, M., Nogueira, L., Oliveira, T., et al. (2016) · Nature · doi:10.1038/nature18929 · Cited by 472
Gray, E. S., Madiga, M. C., Hermanus, T., Moore, P. L., Wibmer, C. K., Tumba, N. L., Werner, L., Mlisana, K., Sibeko, S., Williamson, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00198-11 · Cited by 466
Lynch, R. M., Boritz, E., Coates, E. E., DeZure, A., Madden, P., Costner, P., Enama, M. E., Plummer, S., Holman, L., Hendel, C. S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5752 · Cited by 465
Self-citationAntibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Shingai, M., Nishimura, Y., Klein, F., Mouquet, H., Donau, O. K., Plishka, R., Buckler-White, A., Seaman, M., Piatak, M., Lifson, J. D., et al. (2013) · Nature · doi:10.1038/nature12746 · Cited by 455
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
Kwong, P. D., & Mascola, J. R. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.012 · Cited by 455
Self-citationThe structural biology of type I viral membrane fusion
Colman, P. M., & Lawrence, M. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1076 · Cited by 454
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
Jardine, J. G., Kulp, D. W., Havenar-Daughton, C., Sarkar, A., Briney, B., Sok, D., Sesterhenn, F., Ereño-Orbea, J., Kalyuzhniy, O., Deresa, I., et al. (2016) · Science · doi:10.1126/science.aad9195 · Cited by 450
Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., & Wilson, I. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.011 · Cited by 449
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Stamatatos, L., Morris, L., Burton, D. R., & Mascola, J. R. (2009) · Nature Medicine · doi:10.1038/nm.1949 · Cited by 430
Self-citationStructure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
Kallewaard, N. L., Corti, D., Collins, P. J., Neu, U., McAuliffe, J. M., Benjamin, E., Wachter-Rosati, L., Palmer-Hill, F. J., Yuan, A. Q., Walker, P. A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.073 · Cited by 426
Bonsignori, M., Hwang, K.-K., Chen, X., Tsao, C.-Y., Morris, L., Gray, E., Marshall, D. J., Crump, J. A., Kapiga, S. H., Sam, N. E., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05045-11 · Cited by 423
Self-citationCryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
Lee, J. H., Ozorowski, G., & Ward, A. B. (2016) · Science · doi:10.1126/science.aad2450 · Cited by 421
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
Jardine, J. G., Ota, T., Sok, D., Pauthner, M., Kulp, D. W., Kalyuzhniy, O., Skog, P. D., Thinnes, T. C., Bhullar, D., Briney, B., et al. (2015) · Science · doi:10.1126/science.aac5894 · Cited by 420
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
Huang, J., Kang, B. H., Pancera, M., Lee, J. H., Tong, T., Feng, Y., Imamichi, H., Georgiev, I. S., Chuang, G.-Y., Druz, A., et al. (2014) · Nature · doi:10.1038/nature13601 · Cited by 420
Self-citationTrimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
Stewart-Jones, G. B. E., Soto, C., Lemmin, T., Chuang, G.-Y., Druz, A., Kong, R., Thomas, P. V., Wagh, K., Zhou, T., Behrens, A.-J., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.010 · Cited by 404
Self-citationHIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
Steichen, J. M., Kulp, D. W., Tokatlian, T., Escolano, A., Dosenovic, P., Stanfield, R. L., McCoy, L. E., Ozorowski, G., Hu, X., Kalyuzhniy, O., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.016 · Cited by 401
The Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Self-citationAntibody responses to envelope glycoproteins in HIV-1 infection
Burton, D. R., & Mascola, J. R. (2015) · Nature Immunology · doi:10.1038/ni.3158 · Cited by 385
Self-citationWalker, L. M., Simek, M. D., Priddy, F., Gach, J. S., Wagner, D., Zwick, M. B., Phogat, S. K., Poignard, P., & Burton, D. R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001028 · Cited by 370
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
Huang, J., Kang, B. H., Ishida, E., Zhou, T., Griesman, T., Sheng, Z., Wu, F., Doria-Rose, N. A., Zhang, B., McKee, K., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.027 · Cited by 369
Self-citationZhou, T., Zhu, J., Wu, X., Moquin, S., Zhang, B., Acharya, P., Georgiev, I. S., Altae-Tran, H. R., Chuang, G.-Y., Joyce, M. G., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.012 · Cited by 366
Self-citationSok, D., van Gils, M. J., Pauthner, M., Julien, J.-P., Saye-Francisco, K. L., Hsueh, J., Briney, B., Lee, J. H., Le, K. M., Lee, P. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415789111 · Cited by 364
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
Hraber, P., Seaman, M. S., Bailer, R. T., Mascola, J. R., Montefiori, D. C., & Korber, B. T. (2014) · AIDS · doi:10.1097/qad.0000000000000106 · Cited by 357
Self-citationLabrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C.-C., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10557-10565.2003 · Cited by 357
Self-citationDo Kwon, Y., Pancera, M., Acharya, P., Georgiev, I. S., Crooks, E. T., Gorman, J., Joyce, M. G., Guttman, M., Ma, X., Narpala, S., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3051 · Cited by 345
Self-citationFusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
Kong, R., Xu, K., Zhou, T., Acharya, P., Lemmin, T., Liu, K., Ozorowski, G., Soto, C., Taft, J. D., Bailer, R. T., et al. (2016) · Science · doi:10.1126/science.aae0474 · Cited by 345
Self-citationThe challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Karlsson Hedestam, G. B., Fouchier, R. A. M., Phogat, S., Burton, D. R., Sodroski, J., & Wyatt, R. T. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1819 · Cited by 339
de Taeye, S. W., Ozorowski, G., Torrents de la Peña, A., Guttman, M., Julien, J.-P., van den Kerkhof, T. L. G. M., Burger, J. A., Pritchard, L. K., Pugach, P., Yasmeen, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.056 · Cited by 338
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
Kong, L., Lee, J. H., Doores, K. J., Murin, C. D., Julien, J.-P., McBride, R., Liu, Y., Marozsan, A., Cupo, A., Klasse, P.-J., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2594 · Cited by 337
Doria-Rose, N. A., Klein, R. M., Daniels, M. G., O'Dell, S., Nason, M., Lapedes, A., Bhattacharya, T., Migueles, S. A., Wyatt, R. T., Korber, B. T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01482-09 · Cited by 336
Self-citationAbbott, R. K., Lee, J. H., Menis, S., Skog, P., Rossi, M., Ota, T., Kulp, D. W., Bhullar, D., Kalyuzhniy, O., Havenar-Daughton, C., et al. (2018) · Immunity · doi:10.1016/j.immuni.2017.11.023 · Cited by 336
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
Joyce, M. G., Wheatley, A. K., Thomas, P. V., Chuang, G.-Y., Soto, C., Bailer, R. T., Druz, A., Georgiev, I. S., Gillespie, R. A., Kanekiyo, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.043 · Cited by 333
Self-citationSequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
Escolano, A., Steichen, J. M., Dosenovic, P., Kulp, D. W., Golijanin, J., Sok, D., Freund, N. T., Gitlin, A. D., Oliveira, T., Araki, T., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.030 · Cited by 320
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
Bonsignori, M., Zhou, T., Sheng, Z., Chen, L., Gao, F., Joyce, M. G., Ozorowski, G., Chuang, G.-Y., Schramm, C. A., Wiehe, K., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.022 · Cited by 319
Self-citationStructural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
Zhou, T., Lynch, R. M., Chen, L., Acharya, P., Wu, X., Doria-Rose, N. A., Joyce, M. G., Lingwood, D., Soto, C., Bailer, R. T., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.007 · Cited by 310
Self-citationMcGuire, A. T., Hoot, S., Dreyer, A. M., Lippy, A., Stuart, A., Cohen, K. W., Jardine, J., Menis, S., Scheid, J. F., West, A. P., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122824 · Cited by 309
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Chen, L., Do Kwon, Y., Zhou, T., Wu, X., O’Dell, S., Cavacini, L., Hessell, A. J., Pancera, M., Tang, M., Xu, L., et al. (2009) · Science · doi:10.1126/science.1175868 · Cited by 300
Self-citationAntibody vs. HIV in a clash of evolutionary titans
Burton, D. R., Stanfield, R. L., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505126102 · Cited by 299
Julien, J.-P., Sok, D., Khayat, R., Lee, J. H., Doores, K. J., Walker, L. M., Ramos, A., Diwanji, D. C., Pejchal, R., Cupo, A., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003342 · Cited by 293
Kisalu, N. K., Idris, A. H., Weidle, C., Flores-Garcia, Y., Flynn, B. J., Sack, B. K., Murphy, S., Schön, A., Freire, E., Francica, J. R., et al. (2018) · Nature Medicine · doi:10.1038/nm.4512 · Cited by 293
Self-citationXu, K., Acharya, P., Kong, R., Cheng, C., Chuang, G.-Y., Liu, K., Louder, M. K., O’Dell, S., Rawi, R., Sastry, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0042-6 · Cited by 283
Self-citationRudicell, R. S., Kwon, Y. D., Ko, S.-Y., Pegu, A., Louder, M. K., Georgiev, I. S., Wu, X., Zhu, J., Boyington, J. C., Chen, X., et al. (2014) · Journal of Virology · doi:10.1128/jvi.02213-14 · Cited by 282
Self-citationCooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
Gao, F., Bonsignori, M., Liao, H.-X., Kumar, A., Xia, S.-M., Lu, X., Cai, F., Hwang, K.-K., Song, H., Zhou, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.022 · Cited by 279
Self-citationElicitation of structure-specific antibodies by epitope scaffolds
Ofek, G., Guenaga, F. J., Schief, W. R., Skinner, J., Baker, D., Wyatt, R., & Kwong, P. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004728107 · Cited by 278
Self-citationYang, X., Lee, J., Mahony, E. M., Kwong, P. D., Wyatt, R., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4634-4642.2002 · Cited by 277
Self-citationNabel, G. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1204186 · Cited by 271
Structural and genetic basis for development of broadly neutralizing influenza antibodies
Lingwood, D., McTamney, P. M., Yassine, H. M., Whittle, J. R. R., Guo, X., Boyington, J. C., Wei, C.-J., & Nabel, G. J. (2012) · Nature · doi:10.1038/nature11371 · Cited by 268
Landais, E., Huang, X., Havenar-Daughton, C., Murrell, B., Price, M. A., Wickramasinghe, L., Ramos, A., Bian, C. B., Simek, M., Allen, S., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005369 · Cited by 265
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
Dosenovic, P., von Boehmer, L., Escolano, A., Jardine, J., Freund, N. T., Gitlin, A. D., McGuire, A. T., Kulp, D. W., Oliveira, T., Scharf, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.003 · Cited by 263
Human Immunodeficiency Virus Type 1 Recombination: Rate, Fidelity, and Putative Hot Spots
Zhuang, J., Jetzt, A. E., Sun, G., Yu, H., Klarmann, G., Ron, Y., Preston, B. D., & Dougherty, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11273-11282.2002 · Cited by 262
Xiao, X., Chen, W., Feng, Y., Zhu, Z., Prabakaran, P., Wang, Y., Zhang, M.-Y., Longo, N. S., & Dimitrov, D. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.029 · Cited by 260
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
Briney, B., Sok, D., Jardine, J. G., Kulp, D. W., Skog, P., Menis, S., Jacak, R., Kalyuzhniy, O., de Val, N., Sesterhenn, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.005 · Cited by 255
Doria-Rose, N. A., Bhiman, J. N., Roark, R. S., Schramm, C. A., Gorman, J., Chuang, G.-Y., Pancera, M., Cale, E. M., Ernandes, M. J., Louder, M. K., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01791-15 · Cited by 241
Self-citationLee, J. H., Andrabi, R., Su, C.-Y., Yasmeen, A., Julien, J.-P., Kong, L., Wu, N. C., McBride, R., Sok, D., Pauthner, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.017 · Cited by 239
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection
Wu, X., Zhang, Z., Schramm, C. A., Joyce, M. G., Do Kwon, Y., Zhou, T., Sheng, Z., Zhang, B., O’Dell, S., McKee, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.004 · Cited by 231
Self-citationWest, A. P., Diskin, R., Nussenzweig, M. C., & Bjorkman, P. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208984109 · Cited by 231
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires
Tian, M., Cheng, C., Chen, X., Duan, H., Cheng, H.-L., Dao, M., Sheng, Z., Kimble, M., Wang, L., Lin, S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.029 · Cited by 231
Self-citationNative‐like Env trimers as a platform for HIV‐1 vaccine design
Sanders, R. W., & Moore, J. P. (2017) · Immunological Reviews · doi:10.1111/imr.12481 · Cited by 227
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
Azoitei, M. L., Correia, B. E., Ban, Y.-E. A., Carrico, C., Kalyuzhniy, O., Chen, L., Schroeter, A., Huang, P.-S., McLellan, J. S., Kwong, P. D., et al. (2011) · Science · doi:10.1126/science.1209368 · Cited by 224
Self-citationCorreia, B. E., Ban, Y.-E. A., Holmes, M. A., Xu, H., Ellingson, K., Kraft, Z., Carrico, C., Boni, E., Sather, D. N., Zenobia, C., et al. (2010) · Structure · doi:10.1016/j.str.2010.06.010 · Cited by 218
Sharma, S. K., de Val, N., Bale, S., Guenaga, J., Tran, K., Feng, Y., Dubrovskaya, V., Ward, A. B., & Wyatt, R. T. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.047 · Cited by 213
Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike
Scharf, L., Scheid, J. F., Lee, J. H., West, A. P., Chen, C., Gao, H., Gnanapragasam, P. N. P., Mares, R., Seaman, M. S., Ward, A. B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.001 · Cited by 212
Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization
Georgiev, I. S., Doria-Rose, N. A., Zhou, T., Do Kwon, Y., Staupe, R. P., Moquin, S., Chuang, G.-Y., Louder, M. K., Schmidt, S. D., Altae-Tran, H. R., et al. (2013) · Science · doi:10.1126/science.1233989 · Cited by 212
Self-citationTan, J., Sack, B. K., Oyen, D., Zenklusen, I., Piccoli, L., Barbieri, S., Foglierini, M., Fregni, C. S., Marcandalli, J., Jongo, S., et al. (2018) · Nature Medicine · doi:10.1038/nm.4513 · Cited by 202
Gristick, H. B., von Boehmer, L., West Jr, A. P., Schamber, M., Gazumyan, A., Golijanin, J., Seaman, M. S., Fätkenheuer, G., Klein, F., Nussenzweig, M. C., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3291 · Cited by 200
Bhiman, J. N., Anthony, C., Doria-Rose, N. A., Karimanzira, O., Schramm, C. A., Khoza, T., Kitchin, D., Botha, G., Gorman, J., Garrett, N. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3963 · Cited by 199
Self-citationAndrabi, R., Voss, J. E., Liang, C.-H., Briney, B., McCoy, L. E., Wu, C.-Y., Wong, C.-H., Poignard, P., & Burton, D. R. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.014 · Cited by 192
Medina-Ramírez, M., Garces, F., Escolano, A., Skog, P., de Taeye, S. W., Del Moral-Sanchez, I., McGuire, A. T., Yasmeen, A., Behrens, A.-J., Ozorowski, G., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161160 · Cited by 190
Garces, F., Lee, J. H., de Val, N., Torrents de la Pena, A., Kong, L., Puchades, C., Hua, Y., Stanfield, R. L., Burton, D. R., Moore, J. P., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.007 · Cited by 189
Hessell, A. J., Jaworski, J. P., Epson, E., Matsuda, K., Pandey, S., Kahl, C., Reed, J., Sutton, W. F., Hammond, K. B., Cheever, T. A., et al. (2016) · Nature Medicine · doi:10.1038/nm.4063 · Cited by 187
Self-citationSok, D., Laserson, U., Laserson, J., Liu, Y., Vigneault, F., Julien, J.-P., Briney, B., Ramos, A., Saye, K. F., Le, K., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003754 · Cited by 184
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
Hoot, S., McGuire, A. T., Cohen, K. W., Strong, R. K., Hangartner, L., Klein, F., Diskin, R., Scheid, J. F., Sather, D. N., Burton, D. R., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003106 · Cited by 184
Sok, D., Doores, K. J., Briney, B., Le, K. M., Saye-Francisco, K. L., Ramos, A., Kulp, D. W., Julien, J.-P., Menis, S., Wickramasinghe, L., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008104 · Cited by 183
McGuire, A. T., Gray, M. D., Dosenovic, P., Gitlin, A. D., Freund, N. T., Petersen, J., Correnti, C., Johnsen, W., Kegel, R., Stuart, A. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms10618 · Cited by 182
Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies
Garces, F., Sok, D., Kong, L., McBride, R., Kim, H. J., Saye-Francisco, K. F., Julien, J.-P., Hua, Y., Cupo, A., Moore, J. P., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.009 · Cited by 178
The Antibody Response against HIV-1
Overbaugh, J., & Morris, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007039 · Cited by 177
Gorman, J., Soto, C., Yang, M. M., Davenport, T. M., Guttman, M., Bailer, R. T., Chambers, M., Chuang, G.-Y., DeKosky, B. J., Doria-Rose, N. A., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3144 · Cited by 177
Self-citationPriming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice
Sok, D., Briney, B., Jardine, J. G., Kulp, D. W., Menis, S., Pauthner, M., Wood, A., Lee, E.-C., Le, K. M., Jones, M., et al. (2016) · Science · doi:10.1126/science.aah3945 · Cited by 176
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
Zhou, T., Doria-Rose, N. A., Cheng, C., Stewart-Jones, G. B. E., Chuang, G.-Y., Chambers, M., Druz, A., Geng, H., McKee, K., Kwon, Y. D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.013 · Cited by 176
Self-citationBonsignori, M., Montefiori, D. C., Wu, X., Chen, X., Hwang, K.-K., Tsao, C.-Y., Kozink, D. M., Parks, R. J., Tomaras, G. D., Crump, J. A., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07163-11 · Cited by 175
Self-citationFreund, N. T., Wang, H., Scharf, L., Nogueira, L., Horwitz, J. A., Bar-On, Y., Golijanin, J., Sievers, S. A., Sok, D., Cai, H., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2144 · Cited by 169
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma
Williams, L. D., Ofek, G., Schätzle, S., McDaniel, J. R., Lu, X., Nicely, N. I., Wu, L., Lougheed, C. S., Bradley, T., Louder, M. K., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aal2200 · Cited by 168
Self-citationAntibody‐virus co‐evolution in HIV infection: paths for HIV vaccine development
Bonsignori, M., Liao, H., Gao, F., Williams, W. B., Alam, S. M., Montefiori, D. C., & Haynes, B. F. (2017) · Immunological Reviews · doi:10.1111/imr.12509 · Cited by 168
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
Joyce, M. G., Zhang, B., Ou, L., Chen, M., Chuang, G.-Y., Druz, A., Kong, W.-P., Lai, Y.-T., Rundlet, E. J., Tsybovsky, Y., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3267 · Cited by 167
Self-citationAntibody polyspecificity and neutralization of HIV-1: A hypothesis
Haynes, B. F., Moody, M. A., Verkoczy, L., Kelsoe, G., & Alam, S. M. (2006) · Human Antibodies · doi:10.3233/hab-2005-143-402 · Cited by 163
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
van Gils, M. J., van den Kerkhof, T. L. G. M., Ozorowski, G., Cottrell, C. A., Sok, D., Pauthner, M. G., Pallesen, J., de Val, N., Yasmeen, A., de Taeye, S. W., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.199 · Cited by 159
Sok, D., Pauthner, M. G., Briney, B. S., Lee, J. H., Saye-Francisco, K. L., Hsueh, J., Ramos, A. G., Le, K. M., Jones, M., Jardine, J. G., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.026 · Cited by 151
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
de la Peña, A. T., Julien, J., de Taeye, S. W., Garcés, F., Guttman, M., Ozorowski, G., Pritchard, L. K., Behrens, A., Go, E. P., Burger, J. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.077 · Cited by 148
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design
Jardine, J. G., Sok, D., Julien, J., Briney, B. S., Sarkar, A., Liang, C.-H., Scherer, E. A., Henry, C., Adachi, Y., Diwanji, D. C., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005815 · Cited by 145
Briney, B. S., Willis, J. R., & Crowe, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036750 · Cited by 143
Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus
Liu, J., Ghneim, K., Sok, D., Bosche, W. J., Yuan, L., Chipriano, E., Berkemeier, B., Oswald, K. A., Borducchi, E. N., Cabral, C., et al. (2016) · Science · doi:10.1126/science.aag0491 · Cited by 143
Use of broadly neutralizing antibodies for HIV ‐1 prevention
Pegu, A., Hessell, A. J., Mascola, J. R., & Haigwood, N. L. (2017) · Immunological Reviews · doi:10.1111/imr.12511 · Cited by 142
Self-citationStamatatos, L., Pancera, M., & McGuire, A. T. (2017) · Immunological Reviews · doi:10.1111/imr.12483 · Cited by 141
HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant
Simonich, C. A. L., Williams, K. L., Verkerke, H., Williams, J. A., Nduati, R. W., Lee, K. K., & Overbaugh, J. M. (2016) · Cell · doi:10.1016/j.cell.2016.05.055 · Cited by 140
MacLeod, D. T., Choi, N. M., Briney, B. S., Garcés, F., Ver, L. S., Landais, E., Murrell, B., Wrin, T., Kilembe, W., Liang, C. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.016 · Cited by 139
Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env
Scharf, L., Wang, H., Gao, H., Chen, S., McDowall, A. W., & Björkman, P. J. (2015) · Cell · doi:10.1016/j.cell.2015.08.035 · Cited by 138
Progress toward active or passive HIV-1 vaccination
Escolano, A., Dosenovic, P., & Nussenzweig, M. C. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20161765 · Cited by 137
Mayer, K. H., Seaton, K. E., Huang, Y., Grunenberg, N. A., Isaacs, A., Allen, M., Ledgerwood, J. E., Frank, I., Sobieszczyk, M. E., Baden, L. R., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002435 · Cited by 131
Self-citationDey, B., Svehla, K., Xu, L., Wycuff, D., Zhou, T., Voss, G., Phogat, A., Chakrabarti, B. K., Li, Y., Shaw, G. M., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000445 · Cited by 122
Self-citationGeorgiev, I. S., Joyce, M. G., Yang, Y., Sastry, M., Zhang, B., Baxa, U., Chen, R. E., Druz, A., Lees, C. R., Narpala, S., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03451-14 · Cited by 118
Self-citationBarnes, C. O., Gristick, H. B., Freund, N. T., Escolano, A., Lyubimov, A. Y., Hartweger, H., West, A. P., Cohen, A. E., Nussenzweig, M. C., & Björkman, P. J. (2018) · Nature Communications · doi:10.1038/s41467-018-03632-y · Cited by 113
Ofek, G., McKee, K., Yang, Y., Yang, Z., Skinner, J., Guenaga, J., Wyatt, R. T., Zwick, M. B., Nabel, G. J., Mascola, J. R., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02257-09 · Cited by 111
Self-citationMPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
Ruprecht, C. R., Krarup, A., Reynell, L., Mann, A. M., Brandenberg, O. F., Berlinger, L., Abela, I. A., Regoes, R. R., Günthard, H. F., Rusert, P., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101907 · Cited by 110
Landais, E., Murrell, B., Briney, B. S., Murrell, S., Rantalainen, K. I., Berndsen, Z. T., Ramos, A. G., Wickramasinghe, L., Smith, M. L., Eren, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.002 · Cited by 107
Initiation of immune tolerance–controlled HIV gp41 neutralizing B cell lineages
Zhang, R., Verkoczy, L. K., Wiehe, K. J., Alam, S. M., Nicely, N. I., Santra, S., Bradley, T., Pemble, C. W., IV, Zhang, J., Gao, F., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf0618 · Cited by 106
McLellan, J. S., Correia, B. E., Chen, M., Yang, Y., Graham, B. S., Schief, W. R., & Kwong, P. D. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.044 · Cited by 105
Self-citationQuaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer
Liu, Q., Acharya, P., Dolan, M. A., Zhang, P., Guzzo, C., Lu, J., Kwon, A. L., Gururani, D., Miao, H., Bylund, T., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3382 · Cited by 105
Self-citationIrimia, A., Sarkar, A., Stanfield, R. L., & Wilson, I. A. (2016) · Immunity · doi:10.1016/j.immuni.2015.12.001 · Cited by 103
Gilbert, P. B., Juraska, M., deCamp, A. C., Karuna, S., Edupuganti, S., Mgodi, N. M., Donnell, D. J., Bentley, C., Sista, N. D., Andrew, P., et al. (2017) · Statistical Communications in Infectious Diseases · doi:10.1515/scid-2016-0001 · Cited by 102
Self-citationRutten, L., Lai, Y., Blokland, S., Truan, D., Bisschop, I. J. M., Strokappe, N. M., Koornneef, A., van Manen, D., Chuang, G., Farney, S. K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.061 · Cited by 101
Self-citationPejchal, R., Gach, J. S., Brunel, F. M., Cardoso, R. M. F., Stanfield, R. L., Dawson, P. E., Burton, D. R., Zwick, M. B., & Wilson, I. A. (2009) · Journal of Virology · doi:10.1128/jvi.00685-09 · Cited by 100
Chakrabarti, B. K., Walker, L. M., Guenaga, J., Ghobbeh, A., Poignard, P., Burton, D. R., & Wyatt, R. T. (2011) · Journal of Virology · doi:10.1128/jvi.00756-11 · Cited by 94
Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens
Georgiev, I. S., Joyce, M. G., Chen, R. E., Leung, K., McKee, K., Druz, A., Galen, J. G. V., Kanekiyo, M., Tsybovsky, Y., Yang, E. S., et al. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00192 · Cited by 91
Self-citationBiochemistry of V(D)J Recombination
Schatz, D. G., & Spanopoulou, E. (2005) · Springer eBooks · doi:10.1007/3-540-26363-2_4 · Cited by 89
New concepts in HIV-1 vaccine development
Stephenson, K. E., D’Couto, H. T., & Barouch, D. H. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.05.011 · Cited by 88
Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies
Bird, G. H., Irimia, A., Ofek, G., Kwong, P. D., Wilson, I. A., & Walensky, L. D. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2922 · Cited by 86
Self-citationMimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
Alam, S. M., Aussedat, B., Vohra, Y., Meyerhoff, R. R., Cale, E. M., Walkowicz, W. E., Radakovich, N. A., Anasti, K. M., Armand, L. C., Parks, R., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai7521 · Cited by 85
Self-citationZhou, T., Zheng, A., Baxa, U., Chuang, G., Georgiev, I. S., Kong, R., O'Dell, S. J., Shahzad‐ul‐Hussan, S., Shen, C., Tsybovsky, Y., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.013 · Cited by 83
Self-citationChuang, G., Geng, H., Pancera, M., Xu, K. Y., Cheng, C., Acharya, P., Chambers, M. J., Druz, A., Tsybovsky, Y., Wanninger, T. G., et al. (2017) · Journal of Virology · doi:10.1128/jvi.02268-16 · Cited by 82
Self-citationInitiation of HIV neutralizing B cell lineages with sequential envelope immunizations
Williams, W. B., Zhang, J., Jiang, C., Nicely, N. I., Fera, D., Luo, K., Moody, M. A., Liao, H., Alam, S. M., Kepler, T. B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01336-3 · Cited by 82
Self-citationIrimia, A., Serra, A. M., Sarkar, A., Jacak, R., Kalyuzhniy, O., Sok, D., Saye-Francisco, K. L., Schiffner, T., Tingle, R. D., Kubitz, M., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006212 · Cited by 79
Cale, E. M., Gorman, J., Radakovich, N. A., Crooks, E. T., Osawa, K., Tong, T., Li, J., Raju, N., Ozorowski, G., Ambrozak, D. R., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.011 · Cited by 79
Self-citationTowards HIV-1 remission: potential roles for broadly neutralizing antibodies
Halper-Stromberg, A., & Nussenzweig, M. C. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80561 · Cited by 78
Saunders, K. O., Nicely, N. I., Wiehe, K. J., Bonsignori, M., Meyerhoff, R. R., Parks, R., Walkowicz, W. E., Aussedat, B., Wu, N. R., Cai, F., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.003 · Cited by 78
Farzan, M., Choe, H., Desjardins, E., Sun, Y., Kuhn, J. H., Cao, J., Archambault, D., Kolchinsky, P., Koch, M., Wyatt, R. T., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7620-7625.1998 · Cited by 77
Briney, B. S., Willis, J. R., Hicar, M. D., Thomas, J. W., & Crowe, J. E. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03605.x · Cited by 72
Kwon, Y. D., Chuang, G., Zhang, B., Bailer, R. T., Doria‐Rose, N. A., Gindin, T. S., Lin, B. C., Louder, M. K., McKee, K., O'Dell, S. J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.023 · Cited by 70
Self-citationVoss, J. E., Andrabi, R., McCoy, L. E., de Val, N., Fuller, R. P., Messmer, T., Su, C.-Y., Sok, D., Khan, S. N., Garcés, F., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.024 · Cited by 69
Luallen, R. J., Lin, J., Fu, H., Cai, K. K., Agrawal-Gamse, C., Mboudjeka, I., Lee, F.-H., Montefiori, D. C., Smith, D. F., Doms, R. W., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00412-08 · Cited by 65
Pancera, M., Lebowitz, J., Schön, A., Zhu, P., Freire, E., Kwong, P. D., Roux, K. H., Sodroski, J., & Wyatt, R. T. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9954-9969.2005 · Cited by 65
Self-citationTransplanting Supersites of HIV-1 Vulnerability
Zhou, T., Zhu, J., Yang, Y., Gorman, J., Ofek, G., Srivatsan, S. R., Druz, A., Lees, C. R., Lu, G., Soto, C. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099881 · Cited by 61
Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains
Joyce, M. G., Georgiev, I. S., Yang, Y., Druz, A., Geng, H., Chuang, G., Kwon, Y. D., Pancera, M., Rawi, R., Sastry, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.016 · Cited by 58
Self-citationAgrawal-Gamse, C., Luallen, R. J., Liu, B.-F., Fu, H., Lee, F.-H., Geng, Y., & Doms, R. W. (2010) · Journal of Virology · doi:10.1128/jvi.01349-10 · Cited by 49
Verkoczy, L. K., Alt, F. W., & Tian, M. (2017) · Immunological Reviews · doi:10.1111/imr.12505 · Cited by 45
Unprecedented Role of Hybrid N- Glycans as Ligands for HIV-1 Broadly Neutralizing Antibodies
Shivatare, V. S., Shivatare, S. S., Lee, C.-C. D., Liang, C. J., Liao, K., Cheng, Y., Saidachary, G., Wu, C., Lin, N., Kwong, P. D., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b00896 · Cited by 45
Self-citationIngale, J., Tran, K., Kong, L., Dey, B., McKee, K., Schief, W. R., Kwong, P. D., Mascola, J. R., & Wyatt, R. T. (2014) · Journal of Virology · doi:10.1128/jvi.02614-14 · Cited by 44
Self-citationOntogeny‐based immunogens for the induction of V2‐directed HIV broadly neutralizing antibodies
Moore, P. L., Gorman, J., Doria‐Rose, N. A., & Morris, L. (2017) · Immunological Reviews · doi:10.1111/imr.12501 · Cited by 41
Antibodyomics: bioinformatics technologies for understanding B‐cell immunity to HIV ‐1
Kwong, P. D., Chuang, G., DeKosky, B. J., Gindin, T. S., Georgiev, I. S., Lemmin, T., Schramm, C. A., Sheng, Z., Soto, C. S., Yang, A., et al. (2017) · Immunological Reviews · doi:10.1111/imr.12480 · Cited by 38
Self-citationJoyce, M. G., Kanekiyo, M., Xu, L., Biertümpfel, C., Boyington, J. C., Moquin, S. A., Shi, W., Wu, X., Yang, Y., Yang, Z., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02717-12 · Cited by 35
Self-citationStructure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
Boyington, J. C., Joyce, M. G., Sastry, M., Stewart-Jones, G. B. E., Chen, M., Kong, W., Ngwuta, J. O., Thomas, P. V., Tsybovsky, Y., Yang, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159709 · Cited by 34
Self-citationZhang, H., Fu, H., Luallen, R. J., Liu, B.-F., Lee, F.-H., Doms, R. W., & Geng, Y. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.08.012 · Cited by 19
Chuang, G., Zhou, J., Rawi, R., Shen, C., Sheng, Z., West, A. P., Zhang, B., Zhou, T., Bailer, R. T., Doria‐Rose, N. A., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/312579 · Cited by 3
Self-citation
Cited by
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Mendoza, P., Gruell, H., Nogueira, L., Pai, J. A., Butler, A. L., Millard, K., Lehmann, C., Suárez, I., Oliveira, T. Y., Lorenzi, J. C. C., et al. (2018) · Nature · doi:10.1038/s41586-018-0531-2 · Cited by 521
Self-amplifying RNA vaccines for infectious diseases
Bloom, K., van den Berg, F., & Arbuthnot, P. (2021) · Gene Therapy · doi:10.1038/s41434-020-00204-y · Cited by 487
Exploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 482
Recent progress in broadly neutralizing antibodies to HIV
Sok, D., & Burton, D. R. (2018) · Nature Immunology · doi:10.1038/s41590-018-0235-7 · Cited by 407
Metadata
- Authors
- Kwong, P. D., & Mascola, J. R.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 48
- Issue
- 5
- Pages
- 855-871
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2804113494
- Cited by
- 304
- References
- 192
- FWCI
- 20.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.